Research ArticleMetabolism, Transport, and Pharmacogenomics
Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
Takamitsu Sasaki
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Keita Inami
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Yoshihiro Numata
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Kodai Funakoshi
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Midori Yoshida
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Takeshi Kumagai
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Shuichi Kanno
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Satomi Matsui
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Takayoshi Toriyabe
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Yasushi Yamazoe
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Kouichi Yoshinari
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
Kiyoshi Nagata
Department of Environmental and Health Science (T.S., K.I., Y.N., K.F., M.Y., T.K., K.N.) and Clinical Pharmacotherapeutics (S.K.), Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Aoba-ku, Sendai, Miyagi, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan (T.S., K.Y.); and Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan (S.M., T.T., Y.Y.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleMetabolism, Transport, and Pharmacogenomics
Novel Transactivation of the MRP3 Gene
Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
Journal of Pharmacology and Experimental Therapeutics October 1, 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
Research ArticleMetabolism, Transport, and Pharmacogenomics
Novel Transactivation of the MRP3 Gene
Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
Journal of Pharmacology and Experimental Therapeutics October 1, 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement